Corneal crosslinking combines the use of riboflavin with ultraviolet-A light.

Today announced it provides signed a definitive agreement with Swiss-centered Peschke Meditrade GmbH to obtain the privileges to its Phase III research of Corneal Collagen Crosslinking for the treating progressive post and keratoconus LASIK ectasia. Corneal crosslinking combines the use of riboflavin with ultraviolet-A light. Jointly, these increase corneal power and stability by inducing fresh crosslinks between or within collagen fibers. In multiple international medical trials, crosslinking offers been shown to prevent the progression of keratoconus and ectasia also to enhance the biomechanical balance of the cornea. Crosslinking is approved for the present time use Internationally beyond your US.. Avedro to obtain Corneal Collagen Crosslinking Stage III study privileges from Peschke Meditrade Avedro, Inc.Related StoriesLowering blood pressure below presently recommended targets reduces risk of stroke, heart attackHaving a higher stress job may increase risk of strokeResearchers associate neuroimaging data with reading deficits in individuals with left-sided strokeChocolate is normally rich in antioxidants known as flavonoids which may help lower the risk of strokes. Authored by Sarah Sahib, the intensive research analyzed three studies involving chocolate consumption and stroke risk. One showed there is no association between flavonoid risk and intake of stroke or death. In contrast, another study found a link with stroke for chocolate usage once weekly as opposed to non-e per week. The third study suggested flavonoid intake from eating chocolate lowered death the effect of a stroke weekly.